Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug-drug interaction study of TAS-115 with lansoprazole in healthy subjects
jRCT2071210016Phase 1Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pamufetinib in idiopathic pulmonary fibrosis (IPF), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoints: Cmax of TAS-115, AUClast of TAS-115 and 1 more. Started Jul 2021; status: completed.
02
Drugs
pamufetinib
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on jRCT2071210016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210016.